MannKind Corporation (NASDAQ:MNKD)
Industry: Healthcare

Listed 3 Consecutive Market Days. On List as of 01/23/2012 Through 01/26/2012

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for diabetes and pulmonary arterial hypertension patients. It offers Afrezza, a dry powder formulation of human insulin that controls high blood sugar in adults with type 1 and type 2 diabetes in the United States. The company was founded in 1991 and is headquartered in Westlake Village, California.

Current Quote*
Last: $1.790
Change: -0.060
Book: $Unk
Volume: 3,152,846

As Of: 04/25 12:39 ET
*Quotes delayed by 20min.

Graphs for MNKD


3 Month Graph


6 Month Graph


1 Year Graph